Geduld E E - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 108 filers reported holding HALOZYME THERAPEUTICS INC in Q2 2013. The put-call ratio across all filers is 1.49 and the average weighting 0.4%.

Quarter-by-quarter ownership
Geduld E E ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q3 2015$168,000
-78.8%
12,500
-64.3%
0.16%
-67.9%
Q2 2015$791,000
+57.9%
35,0500.0%0.49%
+47.3%
Q1 2015$501,000
+72.8%
35,050
+16.6%
0.33%
+114.1%
Q4 2014$290,000
-29.3%
30,050
-33.3%
0.16%
-46.2%
Q3 2014$410,000
-17.0%
45,050
-10.0%
0.29%
-5.5%
Q2 2014$494,000
-46.8%
50,050
-31.5%
0.31%
-38.7%
Q1 2014$928,000
-4.7%
73,050
+12.4%
0.50%
+6.6%
Q4 2013$974,000
+35.7%
65,0000.0%0.47%
+7.3%
Q3 2013$718,000
+20.5%
65,000
-13.3%
0.44%
+3.5%
Q2 2013$596,00075,0000.42%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q2 2013
NameSharesValueWeighting ↓
TRAN CAPITAL MANAGEMENT, L.P. 1,084,118$61,686,2857.80%
SNYDER CAPITAL MANAGEMENT L P 3,983,814$226,679,0175.12%
First Light Asset Management, LLC 923,119$52,525,4714.88%
Redwood Investments, LLC 441,809$25,138,9323.37%
BERNZOTT CAPITAL ADVISORS 444,728$25,305,0233.27%
DOHENY ASSET MANAGEMENT /CA 46,050$2,6203.04%
Crawford Lake Capital Management, LLC 42,171$2,399,5302.75%
2Xideas AG 416,586$23,703,7432.51%
Granite Investment Partners, LLC 902,882$51,373,9862.14%
HighMark Wealth Management LLC 41,790$2,377,8511.79%
View complete list of HALOZYME THERAPEUTICS INC shareholders